All the issues and trends impacting retail pharmacy professionals and the industry they serve filter through the 50 state pharmacy associations like currents that feed a larger stream. So the summer meeting of the National Alliance of State Pharmacy Associations served up a laundry list of the most nagging challenges and most promising opportunities facing pharmacy leaders in the coming years, as they confront new reimbursement paradigms, current regulatory hurdles, dramatically new health delivery models and the growing demand for a more patient-centered and more engaged form of pharmacy practice.
Over an uninterrupted, four-and-a-half-hour dialogue Saturday afternoon, dozens of state pharmacy association executives and industry leaders grappled with a wide range of topics that define the challenges and potential facing pharmacy, including:
- Emerging models of healthcare delivery spurred by health reform and the new evidence-based reimbursement paradigm;
- Medication adherence and the role that medication synchronization could play;
- Federal supply chain legislation to establish a nationwide track-and-trace system; and
- New efforts to establish and document the value of pharmacist interventions and new collaborative-practice models.
The meeting marked a new chapter in the relationship between NASPA and the National Association of Chain Drug Stores, NASPA president Ron Fitzwater indicated. “This is the first time we’ve done this, and we’re looking forward to continuing the relationship in the future. It’s a great opportunity to get state pharmacy associations more formally involved with some very important partners,” Fitzwater said, who is also CEO of the Missouri Pharmacy Association.